Current Research Studies

Cancer – ALTE15N2: Late Effects After High-Risk Neuroblastoma Study

Condition or Therapy:



Cancer and Blood Disorders
Study Number: ALTE15N2

What is the goal of this study?

This study looks at patients who have received treatment for high-risk neuroblastoma to establish which treatments are more successful and contain less side effects.

Who can join the study?

This study may be a good fit for individuals who:

  • are 5 to 50 years old,
  • have been enrolled on Children's Oncology Group neuroblastoma biology study ANBL00B1, and
  • have been diagnosed with high-risk neuroblastoma.

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Douglas Hawkins